Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 65/100 | DilutionWatch score record |
| Shares Outstanding | 2.54M | Verified float table or market cache |
| Public Float | 1.91M | Verified float table or market cache |
| Market Cap | $4.95M | Market data cache |
| Cash Runway | 0.1 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | 106.5K | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 5.
Recent SEC source mix: 4 3, XBRL 2.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
TCRT SEC Filing Activity — Last 12 Months
Shares outstanding reported by TCRT on the cover page of its latest 10-K/10-Q: 2.54M as of August 14, 2026.
DilutionWatch recorded 1 registration or prospectus document for TCRT (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 424B3 | prospectus (resale / ATM) | 1 | Sep 21, 2026 |
| 8-K | current report (material event) | 9 | Oct 23, 2026 |
| 10-K | annual report | 1 | Apr 30, 2026 |
| 10-Q | quarterly report | 1 | May 15, 2026 |
| SC 13D/A | amended >5% holder filing | 1 | Oct 15, 2026 |
| 4 | insider transaction | 9 | Oct 08, 2026 |
| 3 | initial insider ownership | 2 | Oct 15, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual TCRT Dilution Snapshot
Alaunos Therapeutics, Inc. (TCRT) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 27, 2026.
- Stored outstanding warrants: 106,452.
- Recent SEC activity tracked for TCRT: xbrl on 2026-08-14; 4 on 2026-01-15; 4 on 2026-01-15.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
TCRT's DilutionScore is currently 65/100 (High risk), with 5 score changes tracked over 89 days. The score deteriorated from 77/100 (Critical risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 01 – Oct 27, 2026 | 65/100 | HIGH | 27 days |
| Sep 28 – Sep 30, 2026 | 77/100 | CRITICAL | 3 days |
| Sep 24 – Sep 27, 2026 | 89/100 | CRITICAL | 4 days |
| Sep 07 – Sep 23, 2026 | 77/100 | CRITICAL | 17 days |
| Aug 14 – Sep 06, 2026 | 89/100 | CRITICAL | 23 days |
| Jul 30 – Aug 13, 2026 | 98/100 | CRITICAL | 15 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
TCRT shares outstanding have increased 9.4% from 2.23M (Apr 2026) to 2.44M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 27, 2026 | 2.44M | 1.91M | ▲ 0.50% |
| May 24, 2026 | 2.44M | 1.90M | ▲ 1.85% |
| May 09, 2026 | 2.40M | 1.87M | ▼ 0.68% |
| May 03, 2026 | 2.38M | 1.88M | ▼ 0.32% |
| Apr 09, 2026 | 2.23M | 1.89M | ▲ 1.74% |
| Apr 03, 2026 | 2.23M | 1.85M | ▲ 6.56% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.